Cholesterol in β-cell dysfunction: The emerging connection between HDL cholesterol and type 2 diabetes

Current Diabetes Reports

Volumn 10, Issue 1, 2010, Pages 55-60

  Brunham, Liam R ^a   Kruit, Janine K ^a   Hayden, Michael R ^a   Verchere, C Bruce ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Beta cell; Cholesterol; HDL; Islet

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ABC TRANSPORTER A1; ADENYLATE KINASE; APOLIPOPROTEIN A1; ETC 216; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; PRAVASTATIN; RECOMBINANT APOLIPOPROTEIN A1; RECOMBINANT HIGH DENSITY LIPOPROTEIN; ROSIGLITAZONE; ROSUVASTATIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ATHEROMA; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; DRUG ACTIVITY; GENETIC POLYMORPHISM; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HETEROZYGOSITY; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID STORAGE; LOSS OF FUNCTION MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; TANGIER DISEASE;

ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS;

EID: 77249121051     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-009-0090-x     Document Type: Review

References (43)

1. MJ Perley DM Kipnis 1967 Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J Clin Invest 46 1954 1962 10.1172/JCI105685 1:CAS:528:DyaF1cXjslGkuw%3D%3D 6074000
2. SE Kahn 2001 The importance of beta-cell failure in the development and progression of type 2 diabetes J Clin Endocrinol Metab 86 4047 4058 10.1210/jc.86.9.4047 1:CAS:528:DC%2BD3MXmvFCktrY%3D 11549624 (Pubitemid 32848511)
3. M Prentki CJ Nolan 2006 Islet beta cell failure in type 2 diabetes J Clin Invest 116 1802 1812 10.1172/JCI29103 1:CAS:528:DC%2BD28XmvV2ltLs%3D 16823478 (Pubitemid 44033300)
4. RH Unger 2002 Lipotoxic diseases Annu Rev Med 53 319 336 10.1146/annurev.med.53.082901.104057 1:CAS:528:DC%2BD38Xitl2mtrc%3D 11818477 (Pubitemid 34177884)
5. LR Brunham JK Kruit CB Verchere, et al. 2008 Cholesterol in islet dysfunction and type 2 diabetes J Clin Invest 118 403 408 10.1172/JCI33296 1:CAS:528:DC%2BD1cXhsFOnurw%3D 18246189 (Pubitemid 351206525)
6. A von Eckardstein H Schulte G Assmann 2000 Risk for diabetes mellitus in middle-aged caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association J Clin Endocrinol Metab 85 3101 3108 10.1210/jc.85.9.3101
7. JM Timmins JY Lee E Boudyguina, et al. 2005 Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I J Clin Invest 115 1333 1342 1:CAS:528: DC%2BD2MXktFSktLg%3D 15841208
8. LR Brunham JK Kruit J Iqbal, et al. 2006 Intestinal ABCA1 directly contributes to HDL biogenesis in vivo J Clin Invest 116 1052 1062 10.1172/JCI27352 1:CAS:528:DC%2BD28XjsVWnurw%3D 16543947
9. RR Singaraja LR Brunham H Visscher, et al. 2003 Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene Arterioscler Thromb Vasc Biol 23 1322 1332 10.1161/01.ATV.0000078520.89539. 77 1:CAS:528:DC%2BD3sXlvFaqsrY%3D 12763760 (Pubitemid 36994518)
10. LR Brunham JK Kruit TD Pape, et al. 2007 Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment Nat Med 13 340 347 10.1038/nm1546 1:CAS:528:DC%2BD2sXisVKku74%3D 17322896 This article provides the first evidence that abnormal cholesterol efflux activity in islets leads to cholesterol accumulation and diminished insulin secretion (Pubitemid 46376682)
11. MT Villarreal-Molina CA Aguilar-Salinas M Rodriguez-Cruz, et al. 2007 The ABCA1 R230C variant affects HDL-cholesterol levels and body mass index in the Mexican population: association with obesity and obesity-related comorbidities Diabetes 56 1881 1887 10.2337/db06-0905 1:CAS:528:DC%2BD2sXnvVWisr8%3D 17287470 (Pubitemid 47025444)
12. MT Villarreal-Molina MT Flores-Dorantes O Arellano-Campos, et al. 2008 Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in the Mexican population Diabetes 57 509 513 10.2337/db07-0484 1:CAS:528:DC%2BD1cXhvVOktLY%3D 18003760
13. J Wang JR Burnett S Near, et al. 2000 Common and rare ABCA1 variants affecting plasma HDL cholesterol Arterioscler Thromb Vasc Biol 20 1983 1989 1:CAS:528:DC%2BD3cXmtFGqtLw%3D 10938021
14. M Koseki A Matsuyama K Nakatani, et al. 2009 Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations J Atheroscler Thromb 16 292 296 1:CAS:528:DC%2BD1MXpt1ehsbc%3D 19556721
15. EJ Schaefer ME Brousseau MR Diffenderfer, et al. 2001 Cholesterol and apolipoprotein B metabolism in Tangier disease Atherosclerosis 159 231 236 10.1016/S0021-9150(01)00688-8 1:CAS:528:DC%2BD3MXnvFCrurk%3D 11689226 (Pubitemid 33016640)
16. F Xia L Xie A Mihic, et al. 2008 Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic {beta}-cells Endocrinology 149 5136 5145 10.1210/en.2008-0161 1:CAS:528:DC%2BD1cXhtF2gur7M 18599549
17. F Xia X Gao E Kwan, et al. 2004 Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis J Biol Chem 279 24685 24691 10.1074/jbc.M314314200 1:CAS:528:DC%2BD2cXksV2iurg%3D 15073181 (Pubitemid 38725336)
18. J Vikman J Jimenez-Feltstrom P Nyman, et al. 2009 Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol FASEB J 23 58 67 10.1096/fj.08-105734 1:CAS:528:DC%2BD1MXlsVOmtg%3D%3D 18806218
19. MA Kennedy GC Barrera K Nakamura, et al. 2005 ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation Cell Metab 1 121 131 10.1016/j.cmet.2005.01.002 1:CAS:528:DC%2BD2MXit12rtbo%3D 16054053 (Pubitemid 43977167)
20. L Yvan-Charvet M Ranalletta N Wang, et al. 2007 Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice J Clin Invest 117 3900 3908 1:CAS:528:DC%2BD2sXhsValsL%2FL 17992262
21. R Out W Jessup W Le Goff, et al. 2008 Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1 Circ Res 102 113 120 10.1161/CIRCRESAHA.107.161711 1:CAS:528:DC%2BD2sXhsVGgtLbN 17967783
22. JL Goldstein RA Bose-Boyd MS Brown 2006 Protein sensors for membrane sterols Cell 124 35 46 10.1016/j.cell.2005.12.022 1:CAS:528: DC%2BD28XntVGlug%3D%3D 16413480 (Pubitemid 43069308)
23. JD Horton I Shimomura MS Brown, et al. 1998 Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2 J Clin Invest 101 2331 2339 10.1172/JCI2961 1:CAS:528:DyaK1cXjvVWrtL0%3D 9616204
24. M Ishikawa Y Iwasaki S Yatoh, et al. 2008 Cholesterol accumulation and diabetes in pancreatic {beta}-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity J Lipid Res 49 2524 2534 10.1194/jlr.M800238-JLR200 1:CAS:528:DC%2BD1cXhsVCjsL7O 18682608 This article reports the results of mice that overexpress SREBP-2 specifically in β cells, leading to cholesterol accumulation and islet dysfunction
25. L Zeng H Liao Y Liu TS Lee, et al. 2004 Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells J Biol Chem 279 48801 48807 10.1074/jbc.M407817200 1:CAS:528:DC%2BD2cXpslGqurk%3D 15358760 (Pubitemid 39625759)
26. ME Roehrich V Mooser V Lenain, et al. 2003 Insulin-secreting beta-cell dysfunction induced by human lipoproteins J Biol Chem 278 18368 18375 10.1074/jbc.M300102200 1:CAS:528:DC%2BD3sXjs1Khsb8%3D 12594227 (Pubitemid 36799458)
27. M Cnop JC Hannaert AY Grupping, et al. 2002 Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification Endocrinology 143 3449 3453 10.1210/en.2002-220273 1:CAS:528:DC%2BD38XmsVSgtbg%3D 12193557 (Pubitemid 34925718)
28. AY Grupping M Cnop CFH Van Schravendijk, et al. 1997 Low density lipoprotein binding and uptake by human and rat islet beta cells Endocrinology 138 4064 4068 10.1210/en.138.10.4064 1:CAS:528:DyaK2sXmsVWgsbk%3D 9322913 (Pubitemid 27408444)
29. S Rutti JA Ehses RA Sibler, et al. 2009 Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic {beta}-cells Endocrinology 150 4521 4530 10.1210/en.2009-0252 1:CAS:528:DC%2BD1MXht1Oktr3I 19628574
30. BG Drew SJ Duffy MF Formosa, et al. 2009 High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus Circulation 119 2103 2111 10.1161/CIRCULATIONAHA.108.843219 1:CAS:528: DC%2BD1MXksVCku7k%3D 19349317 This article provides the first evidence that HDL-based therapies may have beneficial effects on islet function in humans
31. SE Nissen T Tsunoda EM Tuzcu, et al. 2003 Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2292 2300 10.1001/jama.290.17.2292 1:CAS:528:DC%2BD3sXovVCjtbc%3D 14600188 (Pubitemid 37430562)
32. JJ Badimon L Badimon V Fuster 1990 Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit J Clin Invest 85 1234 1241 10.1172/JCI114558 1:CAS:528:DyaK3cXitlehtbw%3D 2318976
33. A Miyazaki S Sakuma W Morikawa, et al. 1995 Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits Arterioscler Thromb Vasc Biol 15 1882 1888 1:CAS:528:DyaK28XhslCgtQ%3D%3D 7583568
34. J Shepherd SM Cobbe I Ford, et al. 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1301 1308 10.1056/NEJM199511163332001 1:CAS:528:DyaK28Xhslemsw%3D%3D 7566020
35. DJ Freeman J Norrie N Sattar, et al. 2001 Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study Circulation 103 357 362 1:CAS:528: DC%2BD3MXhtF2ks7c%3D 11157685
36. PM Ridker E Danielson FA Fonseca, et al. 2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2195 2207 10.1056/NEJMoa0807646 1:CAS:528:DC%2BD1cXhtl2gurnL 18997196
37. SN Rajpathak DJ Kumbhani J Crandall, et al. 2009 Statin therapy and risk of developing type 2 diabetes: a meta-analysis Diabetes Care 32 1924 1929 10.2337/dc09-0738 1:CAS:528:DC%2BD1MXhtlehs7bI 19794004
38. S Sugiyama H Fukushima K Kugiyama, et al. 2007 Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease Atherosclerosis 194 e43 e51 10.1016/j.atherosclerosis.2006.08.023 1:CAS:528:DC%2BD2sXhtFeru7vM 17112529 (Pubitemid 47513070)
39. T Tsutamoto M Yamaji C Kawahara, et al. 2009 Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure Eur J Heart Fail 11 1195 1201 10.1093/eurjhf/hfp144 1:CAS:528:DC%2BD1MXhsVKls7fE 19889690
40. S Li HJ Shin EL Ding, et al. 2009 Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 302 179 188 10.1001/jama.2009.976 1:CAS:528:DC%2BD1MXosVSruro%3D 19584347
41. G Chinetti S Lestavel V Bocher, et al. 2001 PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 53 58 10.1038/83348 1:CAS:528:DC%2BD3MXmvFShtg%3D%3D 11135616 (Pubitemid 32095642)
42. J Wang YQ Bao C Hu, et al. 2008 Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients Acta Pharmacol Sin 29 252 258 10.1111/j.1745-7254.2008.00744.x 1:CAS:528: DC%2BD1cXit1Siurs%3D 18215356 (Pubitemid 351178431)
43. SE Park ES Kang DH Kim, et al. 2009 Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with type 2 diabetes treated with rosiglitazone Diabet Med 26 577 581 10.1111/j.1464-5491.2009.02728.x 1:CAS:528:DC%2BD1MXovFSiu70%3D 19538231